SL

Sebastien Latapie

Principal Avant Bio

New York, New York

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2023

  • Principal

    2023

    Avant Bio is an early-growth and growth equity firm investing in therapeutic enabling technology and health tech companies

  • Principal

    2021

  • Senior Venture Associate

    2019 - 2021

  • Board Observer

    2021

2021

  • Board Observer

    2021

  • Board Observer

    2020

2020

  • Board Observer

    2020

2018 - 2019

  • Venture Capital

    2018 - 2019

2013 - 2017

  • Manager

    2013 - 2017

    New Markets Advisors helps companies create new sources of growth in rapidly changing environments. Focus: setting growth strategies; assessing new and emerging markets; bolstering innovation capabilities; generating new ideas for products, services, and business models Manager (Dec. 2016 - Jul. 2017) Associate (Oct. 2013 - Nov. 2016) Past projects include: Core Growth Project, FinTech Company -- San Fransisco, CA Smart Medical Device Project, Medical Device Company -- Phoenix, AZ Beyond the Pill Growth Project, Pharmaceutical Company -- Germany Digital Health Project, Pharmaceutical Company -- Germany Growth and Differentiation Project, Consumer Bank -- South Africa Market Expansion Project, Healthcare Provider -- Kansas City, MO Innovation Capabilities Project, Pharmaceutical Company -- Cambridge, MA Core Growth Project, Consumer Internet Startup -- South Africa

2013 - 2013

  • Associate Consultant

    2013 - 2013

    Consulting and Business Development Argopoint LLC was founded in 2005 with the goal of improving in-house corporate legal department performance and efficiency at Fortune 500 companies through innovative management consulting services.

2010 - 2012

  • Researcher, Biochemistry

    2010 - 2012